These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34349991)

  • 1. PHLDA1 expression in ulcerative colitis: A potential role in the management of dysplasia.
    Orita F; Ishikawa T; Ishiguro M; Okazaki S; Kikuchi A; Yamauchi S; Matsuyama T; Tokunaga M; Uetake H; Kinugasa Y
    Mol Clin Oncol; 2021 Sep; 15(3):192. PubMed ID: 34349991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
    Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients.
    Lewis A; Felice C; Kumagai T; Lai C; Singh K; Jeffery RR; Feakins R; Giannoulatou E; Armuzzi A; Jawad N; Lindsay JO; Silver A
    PLoS One; 2017; 12(3):e0173664. PubMed ID: 28288169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
    Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
    AbdElazeem MA; El-Sayed M
    Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D receptor expression is associated with colon cancer in ulcerative colitis.
    Wada K; Tanaka H; Maeda K; Inoue T; Noda E; Amano R; Kubo N; Muguruma K; Yamada N; Yashiro M; Sawada T; Nakata B; Ohira M; Hirakawa K
    Oncol Rep; 2009 Nov; 22(5):1021-5. PubMed ID: 19787215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STMN1 accumulation is associated with dysplastic and neoplastic lesions in patients with ulcerative colitis.
    Osone K; Yokobori T; Katayama C; Takahashi R; Kato R; Tatsuski H; Takada T; Yajima R; Motegi Y; Ogawa H; Fujii T; Ojima H; Nakamura J; Yao T; Shirabe K; Kuwano H
    Oncol Lett; 2019 Nov; 18(5):4712-4718. PubMed ID: 31611980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased claudin-1 protein expression contributes to tumorigenesis in ulcerative colitis-associated colorectal cancer.
    Kinugasa T; Akagi Y; Yoshida T; Ryu Y; Shiratuchi I; Ishibashi N; Shirouzu K
    Anticancer Res; 2010 Aug; 30(8):3181-6. PubMed ID: 20871038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the signal transducer and activator of transcription factor 3 and Janus kinase 3 in colorectal carcinomas, colonic adenomas and ulcerative colitis.
    Shareef MM; Shamloula MM; Elfert AA; El-Sawaf M; Soliman HH
    Arab J Gastroenterol; 2009 Mar; 10(1):25-32. PubMed ID: 24842133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulcerative colitis-associated colorectal cancer.
    Yashiro M
    World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the likelihood of colorectal cancer when surgery for ulcerative-colitis-associated dysplasia is deferred?
    Murphy J; Kalkbrenner KA; Blas JV; Pemberton JH; Landmann RG; Young-Fadok TM; Etzioni DA
    Colorectal Dis; 2016 Jul; 18(7):703-9. PubMed ID: 26921877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solute carrier family 12 member 2 as a proteomic and histological biomarker of dysplasia and neoplasia in ulcerative colitis.
    Merli AM; Vieujean S; Massot C; Blétard N; Quesada Calvo F; Baiwir D; Mazzucchelli G; Servais L; Wéra O; Oury C; de Leval L; Sempoux C; Manzini R; Bluemel S; Scharl M; Rogler G; De Pauw E; Coimbra Marques C; Colard A; Vijverman A; Delvenne P; Louis E; Meuwis MA
    J Crohns Colitis; 2020 Sep; ():. PubMed ID: 32920643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with Endoscopically Visible Polypoid Adenomatous Lesions Within the Extent of Ulcerative Colitis Have an Increased Risk of Colorectal Cancer Despite Endoscopic Resection.
    Subramanian V; Chatu S; Echterdiek F; Banerjee A; Finlayson C; Pollok RCG
    Dig Dis Sci; 2016 Oct; 61(10):3031-3036. PubMed ID: 27405991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key genes and biological processes contributing to colitis associated dysplasia in ulcerative colitis.
    Zhang D; Yan P; Han T; Cheng X; Li J
    PeerJ; 2021; 9():e11321. PubMed ID: 33987007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
    Brüwer M; Schmid KW; Senninger N; Schürmann G
    World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of proinflammatory enzyme COX-2 and p53 in ulcerative colitis and its associated dysplasia and colorectal carcinoma.
    Elmashad NM; Ziada DH; Hasby EA; Mohamed AEM
    J Microsc Ultrastruct; 2016; 4(4):195-202. PubMed ID: 30023227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
    Rubin DT; LoSavio A; Yadron N; Huo D; Hanauer SB
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1346-50. PubMed ID: 17059900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.